Product Image

Think Support

Zoi Research
4.6
★ ★ ★ ★ ★
(4130 ratings)
Bacopa 200 mg
Ginkgo
Product Image
Score57
Useful bacopa and ginkgo weights are undermined by missing marker percentages and several opaque supporting blends.
How scoring works
Quantity:180 Capsule(s) • (90 servings)
Goals:
Cognitive Support
Brain Health
Mental Focus
Productivity Boost

Score 57

Useful bacopa and ginkgo weights are undermined by missing marker percentages and several opaque supporting blends.
How scoring works
$50.64($0.56 per serving)
iHerb
$ 50.64
Report prices

Analysis

Bacopin bacopa and ginkgo target memory, learning, and cerebral circulation. The total ginkgo weight is substantial, while bacopa is below the most established daily range.

Neither bacoside nor ginkgo marker percentages are stated. Named marker groups help identify the intended extracts but do not confirm their active yields.

Three proprietary blends conceal supporting ingredients and prevent a complete dose or safety review. The product may suit patient long-term cognitive use, but not users who require full transparency.

Who is it for
  • Adults seeking non-stimulant cognitive support
  • People comfortable with partially proprietary formulas
Best for
  • Long-term memory and learning routines
  • Combining bacopa and ginkgo

Pros

  • Uses named Bacopin bacopa
  • Substantial total ginkgo weight
  • Covers memory and circulation pathways

Cons

  • Bacopa amount is modest
  • Active-marker percentages are missing
  • Three proprietary blends hide supporting ingredients
  • Full dose balance cannot be assessed

Warnings

  • Ginkgo may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Bacopa may cause digestive upset or drowsiness
  • Hidden proprietary ingredients prevent complete medication-interaction screening

Nutrient quality

70 High impact

Recognized bacopa and substantial ginkgo provide a credible cognitive foundation. A modest bacopa amount and hidden supporting blends prevent a complete quality assessment.

.

Ingredient transparency

39 Lower impact

Several named actives have clear amounts, but proprietary components conceal important formula detail. Missing daily directions, excipients, and complete form information further limit label clarity.

.

Customer satisfaction

71 High impact

A strong supplied average is supported by a very large review base. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.

.

Value for money

54 Moderate impact

The larger supply and meaningful ginkgo amount support acceptable value. Hidden blends and incomplete marker disclosure keep the product from leading its category.

.
Report analysis

Goals

Cognitive Support
Impact
High effect
A- Goal FitC- Strength of SupportB- CoverageC Formula Quality
Bacopa · 200 mg

Bacopa and ginkgo create a relevant memory-and-circulation combination with credible human evidence. Bacopa is below the main clinical range, while ginkgo active percentages are not stated.

Several proprietary blends hide supporting amounts and make the full formula difficult to assess. The core pairing is logical, but incomplete standardization weakens confidence in consistent cognitive effects.

Study evidence
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Brain Health
Impact
High effect
B+ Goal FitC- Strength of SupportB- CoverageC- Formula Quality
Bacopa · 200 mg

Bacopa and ginkgo provide a direct memory and cerebral-circulation rationale. Their human evidence is relevant, but several proprietary blends prevent a complete assessment of the formula.

The disclosed bacopa and ginkgo amounts are potentially useful, while the hidden blends obscure the depth of other pathways. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Mental Focus
Impact
Moderate effect
B+ Goal FitD Strength of SupportC- CoverageC- Formula Quality

Bacopa and ginkgo provide a relevant memory and cerebral-circulation combination, but neither extract has enough active-marker disclosure to confirm potency. Bacopa is also below the main clinical amount used by many standardized extracts.

Several proprietary blends hide ingredient identities or quantities, sharply limiting assessment of the full formula. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Productivity Boost
Impact
Moderate effect
B- Goal FitD+ Strength of SupportC- CoverageD Formula Quality

Bacopa and ginkgo provide a plausible long-term memory and attention core. Evidence is moderately supportive, but neither botanical is presented with complete active-marker standardization.

Ginkgo reaches a meaningful listed amount, while Bacopa falls below the main clinical range. Three proprietary blends conceal secondary ingredients and make the broad formula difficult to judge.

Study evidence
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies

Ingredients

IngredientAmount per serving
Proprietary Blend
300 mg
Bacopin (Bacopa Herb Extract)
200 mg
Ginkgo Leaf Extract (Flavonoids, Terpenes)
120 mg
Proprietary Think Support Blend
200 mg
Proprietary Absorption Blend
23 mg
Adults 18–50 Dairy Free
Report overview
D Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyB- Value

The named Bacopin extract offers better consistency than generic Bacopa powder. However, the label does not state its bacoside percentage, so the active yield cannot be verified, and the 200 mg dose falls below the main clinical range. Its near-median serving cost is reasonable for a trademarked extract, but incomplete potency disclosure limits confidence in the value.

F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyF Value

The daily serving lists 240 mg of Ginkgo leaf extracts, but it does not state the standard percentages of key active compounds. The Ginkgo amounts are disclosed separately even though other ingredients appear in proprietary blends. Value is difficult to establish because the extract lacks clear standardization and purity details.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  3. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  6. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  7. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledCognitive Support Brain Health Mental Focus forBacopa
  8. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledMental Focus Brain Health Cognitive Support forBacopa
  9. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  10. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.
    Crawford C; Boyd C; Deuster PA · Journal of alternative and complementary medicine (New York, N.Y.) · 2021
    Systematic review69 studies pooledBrain Health forBacopa
  11. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  12. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  13. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  17. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  18. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  19. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  20. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  21. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  22. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus forBacopa
  23. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  24. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewMental Focus forBacopa
  25. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  26. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  27. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  28. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  29. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsProductivity Boost forBacopa
  30. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  31. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  32. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  33. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  34. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  35. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  36. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo